Jeff Demland

Jeff Demland

As a litigation and estate planning attorney, Jeff helps his clients find meaningful solutions to challenging issues. His experience with the highly regulated healthcare industry allows him to navigate complex rules and find creative solutions for his clients.

Practice Areas

  • Commercial Litigation
  • Trusts and Estates Litigation
  • Estate Planning
  • Probate and Trust Administration
  • Intellectual Property
  • Nonprofit Law

Contact



Jeff focuses his practice on civil litigation and estate planning. His practice grows from his experience in academic and pharmaceutical research, where he worked closely with oncology patients undergoing experimental treatment. He enjoys tackling complex issues, while keeping his clients’ real-world needs at the forefront of every decision.

Jeff listens carefully to his clients to help them find the solution that’s right for them. His experience with scientific research taught him to be resilient and creative, and he enjoys applying this approach to advocate for his clients today.

Outside of Immix, Jeff enjoys home brewing, playing the piano and trombone, and scuba diving with his wife in the cold Pacific Northwest waters.

  • Secretary, Tualatin Community Police Foundation
  • Board Member, M.I.T.C.H. Charter School
  • Member, Multnomah Bar Association
  • Member, Washington County Bar Association

  • Co-Author, “A Phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia,” Blood (February 2011)
  • Author, “Use Pattern and off-label use of atypical antipsychotics in bipolar disorder,” Am. Health Drug Benefits (June 2009)
  • Co-Author, Pneumocystis murina colonization in immunocompetent surfactant protein A deficient mice following environmental exposure, Respir. Res. (February 2009)
  • Co-Author, “Expression of hygromycin phosphotransferase alters virulence of Histoplasma capsulatum,” Eukaryotic Cell (November 2007)
  • Co-Author, “Resolution of Pneumocystis murina infection following withdrawal of corticosteroid induced immunosuppression,” Microb. Pathog. (January 2006)

  • Oregon State Courts
  • U.S. District Court for the District of Oregon
  • Lewis & Clark Law School – J.D., cum laude, 2014
  • University of Cincinnati James. L. Winkle College of Pharmacy – M.S., Drug Development, 2007
  • University of Cincinnati College–Conservatory of Music, B.M., cum laude, Trombone Performance, 2005

Seattle | 206.492.7531
Portland | 503.802.5533